UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

A multi‐centre audit of excess steroid use in 1176 patients with inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2017-11, Vol.46 (10), p.964-973

2017

Volltextzugriff (PDF)

High-resolution magnification endoscopy can reliably identify normal gastric mucosa, Helicobacter pylori-associated gastritis, and gastric atrophy

Endoscopy, 2007-03, Vol.39 (3), p.202-207

2007

Volltextzugriff (PDF)

Downstaging of colorectal cancer by the national bowel cancer screening programme in England: first round data from the first centre

Colorectal disease, 2010-05, Vol.12 (5), p.420-422

2010

Volltextzugriff (PDF)

Attitudes of uk gastroenterology trainees to research and out of programme experience: results from the 2009 national academic training survey

Gut, 2011-04, Vol.60 (Suppl 1), p.A119-A119

2011

Volltextzugriff (PDF)

P226 Dietary patterns differ in the newly diagnosed IBD cohort with ethnicity as a key confounding variable, a case control study

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i379-i381

2023

Volltextzugriff (PDF)

PTH-173 Introduction of the Team Brief and who Safety Checklist in Endoscopy

Gut, 2013-06, Vol.62 (Suppl 1), p.A281-A282

2013

Volltextzugriff (PDF)

PTH-173Introduction of the Team Brief and who Safety Checklist in Endoscopy

Gut, 2013-06, Vol.62 (Suppl 1), p.A281-A282

2013

Volltextzugriff (PDF)

OC-080 Excess Steroid Use in IBD: Too Much, How Much and Why? Results From A Nationwide Audit

Gut, 2016-06, Vol.65 (Suppl 1), p.A47-A47

2016

Volltextzugriff (PDF)

Alternative medicines and the liver

Liver international, 2003-08, Vol.23 (4), p.213-220

2003

Volltextzugriff (PDF)

Eicosanoids in colorectal cancer: non-cyclooxygenase-related mechanisms for aspirin’s chemoprophylactic effects

Fogden, E

2010

Volltextzugriff (PDF)

Managing change in the employment service

Public money & management, 1993-04, Vol.13 (2), p.9-16

Fogden, M. E. G.

1993

Volltextzugriff (PDF)

Widespread amphibian extinctions from epidemic disease driven by global warming

Nature, 2006-01, Vol.439 (7073), p.161-167

2006

Volltextzugriff (PDF)

Single-walled carbon nanotube transparent conductive films fabricated by reductive dissolution and spray coating for organic photovoltaics

Applied physics letters, 2014-12, Vol.105 (25)

2014

Volltextzugriff (PDF)

Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service

Diabetic medicine, 2022-07, Vol.39 (7), p.e14827-n/a

2022

Volltextzugriff (PDF)

Bicontinuous geometries and molecular self-assembly : comparison of local curvature and global packing variations in genus-three cubic, tetragonal and rhombohedral surfaces

The European physical journal. B, Condensed matter physics, 2006-12, Vol.54 (4), p.509-524

2006

Volltextzugriff (PDF)

Endoscopic duodenal‐jejunal bypass liner treatment of moderate obstructive sleep apnoea—A pilot study

Clinical obesity, 2024-08

2024

Volltextzugriff (PDF)

1416-P: UK First National Health Service (NHS) Endobarrier (EB) Service for Uncontrolled Diabesity: Four-Year Outcomes for All 62 Treated Patients

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Duodenal-jejunal bypass liner for treatment of T2DM and obesity: 4-year outcomes in the ﬁrst National Health Service (NHS) EndoBarrier service

British Journal of Diabetes, 2022-12, Vol.22 (2), p.82-86

2022

Volltextzugriff (PDF)

1221-P: UK First National Health Service (NHS) Endobarrier (EB) Service for Uncontrolled Diabesity: Three-Year Outcomes for All 62 Treated Patients

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Global warming and amphibian losses; The proximate cause of frog declines? (Reply)

Nature (London), 2007-05, Vol.447 (7144), p.E5-E6

2007

Volltextzugriff (PDF)

76-OR: UK 1st National Health Service (NHS) EndoBarrier (EB) Service for Uncontrolled Diabesity: 2-Year Outcomes for All 62 Treated Patients

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

2009-P: Improvement in Renal Function Associated with Endobarrier (EB)–Induced Weight Loss

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

The United Kingdom’s first NHS EndoBarrier service for long-standing poorly controlled type 2 diabetes and obesity: outcomes one year after EndoBarrier removal

British Journal of Diabetes, 2021-06, Vol.21 (1), p.76-83

2021

Volltextzugriff (PDF)

The United Kingdom's first NHS Endobarrier service for advanced diabesity: 1-year outcomes for all 62 treated patients

British Journal of Diabetes, 2019-12, Vol.19 (2), p.110-117

2019

Volltextzugriff (PDF)

Endobarrier (EB) in Type 2 Diabetes/Prediabetes with Obstructive Sleep Apnea Study—Preliminary Results

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Englisch
(43)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(14)
Biological And Medical Sciences
(6)
Diabetes Mellitus
(6)
Endocrinology & Metabolism
(6)
Humans
(5)
Diabetes
(4)
Gastroenterology & Hepatology
(4)
Insulin
(4)
Intestine
(4)
Physical Sciences
(4)
Physics
(4)
Alanine
(3)
Alanine Transaminase
(3)
Animals
(3)
Endoscopy
(3)
Exact Sciences And Technology
(3)
Frogs
(3)
Fundamental And Applied Biological Sciences. Psychology
(3)
Male
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A multi‐centre audit of excess steroid use in 1176 patients with inflammatory bowel disease

High-resolution magnification endoscopy can reliably identify normal gastric mucosa, Helicobacter pylori-associated gastritis, and gastric atrophy

Downstaging of colorectal cancer by the national bowel cancer screening programme in England: first round data from the first centre

Attitudes of uk gastroenterology trainees to research and out of programme experience: results from the 2009 national academic training survey

P226 Dietary patterns differ in the newly diagnosed IBD cohort with ethnicity as a key confounding variable, a case control study

PTH-173 Introduction of the Team Brief and who Safety Checklist in Endoscopy

PTH-173Introduction of the Team Brief and who Safety Checklist in Endoscopy

OC-080 Excess Steroid Use in IBD: Too Much, How Much and Why? Results From A Nationwide Audit

Alternative medicines and the liver

Eicosanoids in colorectal cancer: non-cyclooxygenase-related mechanisms for aspirin’s chemoprophylactic effects

Managing change in the employment service

Widespread amphibian extinctions from epidemic disease driven by global warming

Single-walled carbon nanotube transparent conductive films fabricated by reductive dissolution and spray coating for organic photovoltaics

Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service

Bicontinuous geometries and molecular self-assembly : comparison of local curvature and global packing variations in genus-three cubic, tetragonal and rhombohedral surfaces

Endoscopic duodenal‐jejunal bypass liner treatment of moderate obstructive sleep apnoea—A pilot study

1416-P: UK First National Health Service (NHS) Endobarrier (EB) Service for Uncontrolled Diabesity: Four-Year Outcomes for All 62 Treated Patients

Duodenal-jejunal bypass liner for treatment of T2DM and obesity: 4-year outcomes in the ﬁrst National Health Service (NHS) EndoBarrier service

1221-P: UK First National Health Service (NHS) Endobarrier (EB) Service for Uncontrolled Diabesity: Three-Year Outcomes for All 62 Treated Patients

Global warming and amphibian losses; The proximate cause of frog declines? (Reply)

76-OR: UK 1st National Health Service (NHS) EndoBarrier (EB) Service for Uncontrolled Diabesity: 2-Year Outcomes for All 62 Treated Patients

2009-P: Improvement in Renal Function Associated with Endobarrier (EB)–Induced Weight Loss

The United Kingdom’s first NHS EndoBarrier service for long-standing poorly controlled type 2 diabetes and obesity: outcomes one year after EndoBarrier removal

The United Kingdom's first NHS Endobarrier service for advanced diabesity: 1-year outcomes for all 62 treated patients

Endobarrier (EB) in Type 2 Diabetes/Prediabetes with Obstructive Sleep Apnea Study—Preliminary Results

Suchergebnisse filtern